JB Chemicals & Pharmaceuticals Ltd has announced the following Unaudited Results for the quarter ended June 30, 2007.
The Company has posted a profit after tax of Rs 30.714 million for the quarter ended June 30, 2007 where as the same was at Rs 130.112 million for the quarter ended June 30, 2006. Total Income (net of excise) is Rs 1071.793 million for the quarter ended June 30, 2007 where as the same was at Rs 1034.449 million for the quarter ended June 30, 2006.
In view of the effect of Amalgamation of Lekar Healthcare Ltd (LHL) a Wholly Owned Subsidiary of the Company having been given in Q4 of FY 06-07, accounts for the first quarter includes the figures of LHL, hence, the figures for the first quarter are not comparable with the similar period of the previous year.
The company has reported an Earnings Per Share (EPS) of Rs.0.36 for the quarter ended June 30, 2007 compared to Rs.1.55 during quarter ended June 30, 2006.
The stock closed on Friday at Rs.66.20, up by Rs.0.05 or 0.08%. The total traded quantity was 71868 compared to 2 week average of 53792. The stock hit an intraday high of Rs.68 and low of Rs.65.80.